Surrogate markers for late cardiac allograft survival (Q40503705)

21 September 2017

Surrogate markers for late cardiac allograft survival (English)

1 reference

21 September 2017

1

1 reference

21 September 2017

Ray Benza

2

1 reference

21 September 2017

Mario C Deng

series ordinal

3

1 reference

21 September 2017

Stuart Russell

series ordinal

4

1 reference

21 September 2017

Steven Webber

series ordinal

5

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

American Journal of Transplantation

21 September 2017

1 reference

21 September 2017

4

1 reference

21 September 2017

7

1 reference

21 September 2017

1184-1191

1 reference

Cardiac allograft vasculopathy: a review.

21 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Predictive model to assess risk for cardiac allograft vasculopathy: an intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Prognostic importance of intimal thickness as measured by intracoronary ultrasound after cardiac transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Crossing the vasculopathy bridge from morphology to therapy: a single center experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

TOR inhibitors and cardiac allograft vasculopathy: is inhibition of intimal thickening an adequate surrogate of benefit?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Reproducibility of serial intravascular ultrasound measurements in patients with angiographically silent coronary artery disease after heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Heterogeneity of cardiac allograft vasculopathy: clinical insights from coronary angioscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Dobutamine stress echocardiography early after heart transplantation predicts development of allograft coronary artery disease and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Resting echocardiography and quantitative dipyridamole technetium-99m sestamibi tomography in the identification of cardiac allograft vasculopathy and the prediction of long-term prognosis after heart transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Prediction of mortality in heart transplant recipients by stress technetium-99m tetrofosmin myocardial perfusion imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Detection and prediction of acute heart transplant rejection with the myocardial T2 determination provided by a black-blood magnetic resonance imaging sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

The influence of conventional and cross-reactive group HLA matching on cardiac transplant outcome: an analysis from the United Network of Organ Sharing Scientific Registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Value of cardiac troponin I and T for selection of heart donors and as predictors of early graft failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Vascular tissue plasminogen activator and the development of coronary artery disease in heart-transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Gene polymorphisms for plasminogen activator inhibitor-1/tissue plasminogen activator and development of allograft coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

T-cell and monocyte subsets, inflammatory molecules, rejection, and hemodynamics early after cardiac transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Plasma C-reactive protein as a marker of cardiac allograft vasculopathy in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

B-type natriuretic peptide in heart transplantation: an important marker of allograft performance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Usefulness of B-type natriuretic peptide levels in predicting hemodynamic perturbations after heart transplantation despite preserved left ventricular systolic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

Identification of ICAM-1 polymorphism that is associated with protection from transplant associated vasculopathy after cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

C-Reactive protein and cardiac allograft vasculopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00485.X

10.1111/J.1600-6143.2004.00485.X

21 January 2018

Identifiers

DOI

1 reference

21 September 2017

1 reference